Limbix Health, Inc. – Trademark Portfolio
Entity Type: 03
Limbix Health, Inc. holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 4 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 3 Nice Classification classes. Currently, 1 trademark is registered and 2 are pending. Notable registered marks include LIMBOT. The owner is based in San Francisco, CA.
548 Market St. PMB 91609
San Francisco, CA 94104
Showing of trademarks Trademarks
Trademark Classifications
Limbix Health, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Limbix Health, Inc. have?
Limbix Health, Inc. has 6 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 pending, 3 abandoned.
What trademark classes does Limbix Health, Inc. file in?
Limbix Health, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 44 (Medical Services), Class 42 (Computer & Scientific). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are Limbix Health, Inc.'s most well-known trademarks?
Limbix Health, Inc.'s registered trademark portfolio includes well-known marks such as LIMBOT. These are among 1 currently registered trademark in the portfolio.
What is Limbix Health, Inc.'s trademark registration success rate?
Limbix Health, Inc. has a 25% trademark registration rate, with 1 out of 4 resolved applications resulting in successful registration. Currently, 2 applications are pending review.